Related Experiment Video
Updated: May 26, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Prognostic implications of leg ulcers from hydroxycarbamide therapy in patients with essential thrombocythaemia
Sebastian Francis1, David Bareford, Christina Baggott
1Department of Haematology, Russells Hall Hospital, Dudley, UK. seb1976@liv.ac.uk
Abstract:
Essential thrombocythemia (ET) is a clonal stem-cell disorder characterized by persistent thrombocytosis. Patients with ET and risk factors for thrombotic complications have been shown to benefit from cytoreductive therapy, the most common agent used being, hydroxycarbamide. Although this agent is usually well-tolerated, one of the recognized adverse effects is the development of leg ulcers. We undertook retrospective analysis of consecutive ET patients treated with hydroxcarbamide and identified several specific features for this complication including advanced age, female preponderance, reduced overall survival, tendency to develop future vascular events and intolerance to the second line agent, anagrelide.
Related Concept Videos
Diabetic Foot Ulcer
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Varicose Veins II: Diagnostic Studies and Interprofessional Care
